Lowell Anthony

6.7k total citations · 1 hit paper
175 papers, 5.0k citations indexed

About

Lowell Anthony is a scholar working on Epidemiology, Oncology and Neurology. According to data from OpenAlex, Lowell Anthony has authored 175 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 132 papers in Epidemiology, 120 papers in Oncology and 104 papers in Neurology. Recurrent topics in Lowell Anthony's work include Neuroendocrine Tumor Research Advances (129 papers), Neuroblastoma Research and Treatments (103 papers) and Lung Cancer Research Studies (86 papers). Lowell Anthony is often cited by papers focused on Neuroendocrine Tumor Research Advances (129 papers), Neuroblastoma Research and Treatments (103 papers) and Lung Cancer Research Studies (86 papers). Lowell Anthony collaborates with scholars based in United States, Germany and Sweden. Lowell Anthony's co-authors include Thomas M. O’Dorisio, Eugene A. Woltering, Rodney F. Pommier, David S. Klimstra, Matthew H. Kulke, James C. Yao, Robert T. Jensen, Kevin E. McCarthy, Larry K. Kvols and Jonathan Strosberg and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Internal Medicine.

In The Last Decade

Lowell Anthony

168 papers receiving 4.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Consensus Guidelines for the Management and Treatment of Neuroendocrine Tumors

2013 426 citations Pamela L. Kunz, Diane Reidy‐Lagunes et al. Pancreas profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lowell Anthony United States	34	3.8k	3.7k	2.7k	471	368	175	5.0k
Pamela L. Kunz United States	33	2.5k 0.7×	2.9k 0.8×	1.8k 0.7×	712 1.5×	294 0.8×	101	4.1k
Daniel M. Halperin United States	20	3.4k 0.9×	3.1k 0.9×	2.1k 0.8×	222 0.5×	248 0.7×	102	4.2k
Timothy J. Hobday United States	34	3.9k 1.0×	4.7k 1.3×	2.7k 1.0×	678 1.4×	1.1k 3.1×	138	6.3k
Nicola Fazio Italy	45	4.0k 1.0×	4.8k 1.3×	2.7k 1.0×	1.2k 2.6×	498 1.4×	270	6.5k
Halfdan Sørbye Norway	42	3.4k 0.9×	6.5k 1.8×	2.1k 0.8×	1.3k 2.7×	498 1.4×	160	8.1k
Roberto Buzzoni Italy	33	1.3k 0.3×	2.5k 0.7×	937 0.3×	678 1.4×	459 1.2×	165	3.7k
Enrique Grande Spain	35	1.4k 0.4×	2.5k 0.7×	966 0.4×	1.2k 2.6×	1.1k 2.9×	286	4.6k
Laëtitia Dahan France	36	1.9k 0.5×	3.5k 1.0×	1.2k 0.4×	1.7k 3.5×	855 2.3×	144	5.3k
Florencia G. Que United States	42	2.1k 0.5×	3.3k 0.9×	1.1k 0.4×	1.5k 3.2×	381 1.0×	105	5.5k
C G Moertel United States	34	2.1k 0.5×	5.6k 1.5×	1.4k 0.5×	1.6k 3.4×	681 1.9×	77	7.6k

Countries citing papers authored by Lowell Anthony

Since Specialization

Citations

This map shows the geographic impact of Lowell Anthony's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lowell Anthony with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lowell Anthony more than expected).

Fields of papers citing papers by Lowell Anthony

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lowell Anthony. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lowell Anthony. The network helps show where Lowell Anthony may publish in the future.

Co-authorship network of co-authors of Lowell Anthony

This figure shows the co-authorship network connecting the top 25 collaborators of Lowell Anthony. A scholar is included among the top collaborators of Lowell Anthony based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lowell Anthony. Lowell Anthony is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Johnson, Jeremy A., Aman Chauhan, Jong Cheol Jeong, et al.. (2024). Inhibition of ribonucleotide reductase subunit M2 enhances the radiosensitivity of metastatic pancreatic neuroendocrine tumor. Cancer Letters. 596. 216993–216993. 5 indexed citations

Chauhan, Aman, Charles A. Kunos, Susanne M. Arnold, et al.. (2024). A phase II randomized control trial of triapine plus lutetium 177 DOTATATE versus lutetium 177 DOTATATE alone for well-differentiated somatostatin receptor-positive neuroendocrine tumors.. Journal of Clinical Oncology. 42(16_suppl). TPS4202–TPS4202.

Anthony, Lowell, et al.. (2023). Prescribing Characteristics of Octreotide Immediate-Release and Long-Acting Release in Patients with Neuroendocrine Tumors. The Oncologist. 28(6). 479–485. 2 indexed citations

Ragab, Ahmed, Jianrong Wu, Xue Ding, et al.. (2020). 68Ga-DOTATATE PET/CT: The Optimum Standardized Uptake Value (SUV) Internal Reference. Academic Radiology. 29(1). 95–106. 5 indexed citations

Weickert, Martin O., Gregory Kaltsas, Dieter Hörsch, et al.. (2018). Efficacy and Safety of Telotristat Ethyl in Patients With Carcinoid Syndrome Inadequately Controlled by Somatostatin Analogs : Analysis of the Completed TELESTAR Extension Period. Pancreas. 47(3). 341–342. 2 indexed citations

Dillon, Joseph S., Matthew H. Kulke, Marianne Pavel, et al.. (2018). Time to Sustained Improvement in Bowel Movement Frequency With Telotristat Ethyl : Analysis of the Phase 3 TELESTAR Study. Pancreas. 47(3). 337–338. 2 indexed citations

Chu, Zhengtao, Min Jiang, Sheryl E. Koch, et al.. (2017). mTOR Kinase Inhibition Effectively Decreases Progression of a Subset of Neuroendocrine Tumors that Progress on Rapalog Therapy and Delays Cardiac Impairment. Molecular Cancer Therapeutics. 16(11). 2432–2441. 13 indexed citations

Pavel, Marianne, Marta Benavent, M. Caplin, et al.. (2017). Efficacy and Safety Results of Telotristat Ethyl in Patients With Carcinoid Syndrome During the Double-blind Treatment Period of the TELECAST Phase 3 Clinical Trial. Pancreas. 46(3). 434–435. 5 indexed citations

Kulke, Matthew H., Dieter Hoersch, Martyn Caplin, et al.. (2016). Telotristat etiprate shows benefit in treating patients With carcinoid syndrome that is inadequately controlled by somatostatin analog therapy in the phase 3 TELESTAR clinical trial. Pancreas. 45(3). 478–478. 1 indexed citations

10.

Anthony, Lowell, Dieter Hoersch, Matthew H. Kulke, et al.. (2016). Assessing Treatment Benefit of Telotristat Etiprate in Patients with Carcinoid Syndrome : Patient Exit Interviews. Pancreas. 45(3). 470–470. 1 indexed citations

11.

Kulke, Matthew H., Dieter Hörsch, Martyn Caplin, et al.. (2016). Integrated placebo-controlled safety analysis from clinical studies of telotristat ethyl for the treatment of carcinoid syndrome. Annals of Oncology. 27. vi138–vi138. 5 indexed citations

12.

Valentino, Joseph, Jing Li, Yekaterina Y. Zaytseva, et al.. (2014). Cotargeting the PI3K and RAS Pathways for the Treatment of Neuroendocrine Tumors. Clinical Cancer Research. 20(5). 1212–1222. 53 indexed citations

13.

Kunz, Pamela L., Diane Reidy‐Lagunes, Lowell Anthony, et al.. (2013). Consensus Guidelines for the Management and Treatment of Neuroendocrine Tumors. Pancreas. 42(4). 557–577. 426 indexed citations breakdown →

14.

Wang, Yi‐Zarn, et al.. (2012). Cervical and Upper Mediastinal Lymph Node Metastasis from Gastrointestinal and Pancreatic Neuroendocrine Tumors: True Incidence and Management. Journal of the American College of Surgeons. 214(6). 1017–1022. 4 indexed citations

15.

Kvols, Larry K., Bertram Wiedenmann, Kjell Öberg, et al.. (2010). Efficacy, Safety and Pharmacokinetic Results from a Phase II Study of Pasireotide (SOM230) in the Treatment of Patients with Metastatic NETs Refractory or Resistant to Octreotide LAR. Neuroendocrinology. 92(1). 42–43. 5 indexed citations

16.

Anthony, Lowell, Jonathan Strosberg, David S. Klimstra, et al.. (2010). The NANETS Consensus Guidelines for the Diagnosis and Management of Gastrointestinal Neuroendocrine Tumors (NETs). Pancreas. 39(6). 767–774. 207 indexed citations

17.

Delpassand, Ebrahim S., Jennifer Sims‐Mourtada, Hitomi Saso, et al.. (2008). Safety and Efficacy of Radionuclide Therapy with High-Activity In-111 Pentetreotide in Patients with Progressive Neuroendocrine Tumors. Cancer Biotherapy and Radiopharmaceuticals. 23(3). 292–300. 40 indexed citations

18.

Maroun, Jean A., Lowell Anthony, Normand Blais, et al.. (2007). Prevention and Management of Chemotherapy-Induced Diarrhea in Patients with Colorectal Cancer: A Consensus Statement by the Canadian Working Group on Chemotherapy-Induced Diarrhea. Current Oncology. 14(1). 13–20. 109 indexed citations

19.

Anthony, Lowell. (2007). Irinotecan toxicity. Current Opinion in Supportive and Palliative Care. 1(1). 35–39. 9 indexed citations

20.

Anthony, Lowell, et al.. (1998). Echocardiographic and biochemical evaluation of the development and progression of carcinoid heart disease. Journal of the American College of Cardiology. 32(4). 1017–1022. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact